Search Results 1191-1200 of 18639 for Enzyme replacement therapy

1. A Study Of Using Proton Beam Therapy Which Spares Mucosal Tissue Following The Removal Of Oropharyngeal Tumors - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic Health Letter · Healthy Lifestyle. Featured conditions. Brain tumor, breast cancer ...

2. Ph 1b Study to Evaluate GSK2110183 in Combination with Bortezomib and Dexamethasone in Subjects with Multiple Myeloma - Mayo Clinic

   Drugs & Supplements A-Z ... Females on hormone replacement therapy (HRT) and ... Hepatitis B carrier is defined as HBsAg and HBcAb positive by liver enzymes (AST ...

3. Gemcitabine Hydrochloride Alone or With M6620 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer - Mayo Clinic

   Drugs & Supplements A-Z ... ATR kinase inhibitor M6620 may stop the growth of tumor cells by blocking an enzyme ... All acute, clinically significant treatment- ...

4. Clinical trials - Oncology (Medical)

   ... treatment (refractory). Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing cancer cell proliferation and causing cell death.

5. Pioglitazone and glimepiride (oral route) - Side effects & dosage - Mayo Clinic

   ... treatment for you. If both medicines are ... Glucose 6-phosphate dehydrogenase (G6PD) deficiency (an enzyme problem), history of or ... supplements. Back ...

6. Integrative Oncology - Overview - Mayo Clinic

   ... treatment. Dietary supplement counseling. There are many supplements recommended by many sources to people with cancer. However, not all supplements work as ...

7. Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial - Mayo Clinic

   Is the treatment strategy of percutaneous left atrial catheter ablation for the purpose of eliminating atrial fibrillation (AF) superior to the current state-of ...

8. Prophylaxis Versus Preemptive Therapy for the Prevention of CMV in Liver Transplant Recipients - Mayo Clinic

   About this study. This is a study of two different approaches for the prevention of CMV disease in liver transplant recipients. The primary purpose is to ...

9. Cyclobenzaprine (oral route) - Mayo Clinic

   Drugs & Supplements ... However, this medicine does not take the place of rest, exercise or physical therapy, or other treatment that your doctor may recommend ...

10. A Study to Evaluate the Combination of Binimetinib and Palbociclib in Treating Patients with KRAS and NRAS Mutant Metastatic or Unresectable Colorectal Cancer - Mayo Clinic

    Drugs & Supplements A-Z ... treatment works better than the current standard therapy. ... Binimetinib and palbociclib may stop the growth of tumor cells by blocking ...